Gaudium IVF shares list at 5% premium over IPO price on NSE, beat grey market estimates

Gaudium shares listed on the exchanges on February 27.

• Gaudium IVF shares listed at 5 percent premium over IPO price.
• First fertility care company to tap Indian public markets.
• IPO proceeds to fund 19 new IVF centres and repay debt.

Did our AI summary help?

Gaudium IVF shares listed at 5 percent premium over its initital public offer (IPO) price on the National Stock Exchange (NSE), beating the grey market estimates. The issue received 7.27 times subscription in the primary market between February 20-24.  With this, Gaudium IVF becomes the first company in the fertility care sector to tap the public markets.

Shares of Gaudium IVF and Women Health were listed at Rs 83 per share on the NSE, a premium of 5.06 percent. The Rs 165-crore IPO had a price band of Rs 75-79 per share.

On the BSE, the shares of the company were listed at Rs 83 per share. The company's market capitalisation post lising of shares stood at Rs 604.13-crore.

Shares of Gaudium IVF were commanding a flat grey market premium (GMP) in the unofficial market.

Check All IPO News

Proceeds from the fresh issue are intended to establish 19 new IVF centres across India, along with payment of debt and for general corporate purposes. Founded by Khanna, Gaudium IVF has established itself as a pioneer in assisted reproductive technologies in India. It operates through a hub-and-spoke model, with seven hubs and 28 spokes across multiple states.

Financially, the company reported revenue from operations of Rs 70.72 crore and a profit after tax (PAT) of Rs 19.13 crore for the financial year ending March 31, 2025. In FY24, revenue was Rs 47.89 crore, with a PAT of Rs 10.31 crore.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.